ETSY INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that ETSY INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $441.23M | Mar 1, 2018 |
| FY2017 | Dec 31, 2016 | $364.97M | Mar 1, 2018 |
| FY2017 | Dec 31, 2015 | $273.50M | Mar 1, 2018 |
| FY2016 | Dec 31, 2014 | $195.59M | Feb 28, 2017 |
| FY2015 | Dec 31, 2013 | $125.02M | Mar 1, 2016 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.88B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $2.81B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $2.75B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $2.57B | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $2.33B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $1.73B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $818.38M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $603.69M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $441.23M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $364.97M | Feb 28, 2019 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $441.23M | Mar 1, 2018 |
| FY2017 | Dec 31, 2016 | $364.97M | Mar 1, 2018 |
| FY2017 | Dec 31, 2015 | $273.50M | Mar 1, 2018 |
| FY2016 | Dec 31, 2014 | $195.59M | Feb 28, 2017 |
| FY2015 | Dec 31, 2013 | $125.02M | Mar 1, 2016 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.07B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $2.03B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $1.92B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $1.82B | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $1.67B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $1.26B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $547.34M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $412.93M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $290.25M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $241.64M | Feb 28, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $162.98M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $303.28M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $307.57M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | ($694.29M) | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $493.51M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $349.25M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $95.89M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $77.49M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $81.80M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | ($29.90M) | Feb 28, 2019 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $266.21M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $380.21M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $279.84M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | ($658.56M) | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $465.73M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $424.01M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $88.76M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $74.79M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $11.90M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $17.58M | Feb 28, 2019 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $450.19M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $443.06M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $469.33M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $412.40M | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $271.54M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $180.08M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $121.88M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $97.25M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $74.62M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $55.08M | Feb 28, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $693.41M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $752.47M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $705.51M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $683.61M | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $651.55M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $678.96M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $206.92M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $198.93M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $69.10M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $47.96M | Feb 28, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $15.39M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $14.21M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $12.95M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $10.24M | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $11.25M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $1.45M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $7.53M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $1.02M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $3.95M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $35.98M | Feb 28, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.83B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $2.42B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $2.69B | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $2.63B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $3.83B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $2.40B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $1.54B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $901.85M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $605.58M | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $581.19M | Mar 1, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.93B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $3.18B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $3.23B | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $3.18B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $3.20B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $1.66B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $1.14B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $500.95M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $208.69M | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $236.44M | Mar 1, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.10B) | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | ($758.87M) | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | ($543.72M) | Feb 19, 2026 |
| FY2025 | Dec 31, 2022 | ($547.27M) | Feb 19, 2026 |
| FY2024 | Dec 31, 2021 | $628.62M | Feb 19, 2025 |
| FY2023 | Dec 31, 2020 | $742.42M | Feb 22, 2024 |
| FY2022 | Dec 31, 2019 | $406.63M | Feb 23, 2023 |
| FY2021 | Dec 31, 2018 | $400.90M | Feb 25, 2022 |
| FY2020 | Dec 31, 2017 | $396.89M | Feb 26, 2021 |
| FY2019 | Dec 31, 2016 | $344.76M | Feb 27, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $38.07M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $137.09M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $138.38M | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $137.72M | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | $1.37B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $140.81M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $138.73M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $37.48M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $38.54M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $35.66M | Feb 28, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($2.40B) | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | ($1.78B) | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | ($1.36B) | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | ($1.05B) | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $71.74M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | ($146.82M) | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | ($227.41M) | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | ($153.44M) | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | ($96.29M) | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | ($116.34M) | Mar 1, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.40B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $811.18M | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $914.32M | Feb 19, 2026 |
| FY2023 | Dec 31, 2022 | $921.28M | Feb 22, 2024 |
| FY2023 | Dec 31, 2021 | $780.20M | Feb 22, 2024 |
| FY2023 | Dec 31, 2020 | $1.24B | Feb 22, 2024 |
| FY2022 | Dec 31, 2019 | $443.29M | Feb 23, 2023 |
| FY2021 | Dec 31, 2018 | $366.99M | Feb 25, 2022 |
| FY2020 | Dec 31, 2017 | $315.44M | Feb 26, 2021 |
| FY2019 | Dec 31, 2016 | $181.59M | Feb 27, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.33B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $2.29B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $2.28B | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | $2.28B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $2.28B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $1.06B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $785.13M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $276.49M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $0 | Feb 28, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | (5) | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | 3 | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | 2 | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | 0 | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | 0 | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | 0 | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | 0 | Feb 28, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1 | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | 2 | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | 2 | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | (5) | Feb 19, 2025 |
| FY2023 | Dec 31, 2021 | 3 | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | 2 | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | 0 | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | 0 | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | 0 | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | 0 | Feb 28, 2019 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 97.03M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | 108.54M | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | 119.07M | Feb 19, 2025 |
| FY2023 | Dec 31, 2022 | 125.05M | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | 127.02M | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | 125.84M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | 118.34M | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | 119.77M | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | 121.77M | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | 115.97M | Mar 1, 2018 |